Table 4.

Adverse events.

Adverse event	Grade 1-2, N (%)	Grade ≥3, N (%)	Any grade, N (%)
Neutropenia	8 (32)	1 (4)	9 (36)
Decreased platelet count	6 (24)	1 (4)	7 (28)
Nausea and Vomiting	1 (4)	1 (4)	2 (8)
Liver dysfunction	2 (8)	2 (8)	4 (16)
Hand-foot syndrome	4 (16)	3 (12)	7 (28)
Gastric hemorrhage	0	1 (4)	1 (4)
Diarrhea	1 (4)	1 (4)	2 (8)
Fever	2 (8)	1 (4)	3 (12)
Hyperthyroidism	4 (16)	0	4 (16)
Hypothyroidism	2 (8)	0	2 (8)
Hyperglycemia	1 (4)	1 (4)	2 (8)
RCCEP	8 (32)	0	8 (32)
Vision changes	1 (4)	0	1 (4)
Myocarditis	2 (8)	0	2 (8)
Infusion-related reactions	2 (8)	0	2 (8)
ALL	16 (64)	8 (32)	18 (72)

RCCEP, reactive cutaneous capillary endothelial proliferation.